| 000 | 01788 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250515001637.0 | ||
| 264 | 0 | _c20060119 | |
| 008 | 200601s 0 0 eng d | ||
| 022 | _a0042-6822 | ||
| 024 | 7 |
_a10.1016/j.virol.2005.08.007 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aArmand-Ugón, Mercedes | |
| 245 | 0 | 0 |
_aThe anti-HIV activity of ADS-J1 targets the HIV-1 gp120. _h[electronic resource] |
| 260 |
_bVirology _cDec 2005 |
||
| 300 |
_a141-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAmino Acid Sequence |
| 650 | 0 | 4 | _aAmino Acid Substitution |
| 650 | 0 | 4 |
_aAnti-HIV Agents _xpharmacology |
| 650 | 0 | 4 | _aCell Line |
| 650 | 0 | 4 |
_aDrug Resistance, Viral _xgenetics |
| 650 | 0 | 4 | _aEnfuvirtide |
| 650 | 0 | 4 |
_aHIV Core Protein p24 _xanalysis |
| 650 | 0 | 4 |
_aHIV Envelope Protein gp120 _xdrug effects |
| 650 | 0 | 4 |
_aHIV Envelope Protein gp41 _xpharmacology |
| 650 | 0 | 4 |
_aHIV-1 _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMolecular Sequence Data |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 | _aMutation, Missense |
| 650 | 0 | 4 |
_aNaphthalenesulfonates _xpharmacology |
| 650 | 0 | 4 |
_aPeptide Fragments _xpharmacology |
| 650 | 0 | 4 | _aPolyelectrolytes |
| 650 | 0 | 4 |
_aPolymers _xpharmacology |
| 650 | 0 | 4 | _aProtein Binding |
| 650 | 0 | 4 |
_aT-Lymphocytes _xvirology |
| 650 | 0 | 4 |
_aTriazines _xpharmacology |
| 650 | 0 | 4 |
_aVirus Replication _xdrug effects |
| 700 | 1 | _aClotet-Codina, Imma | |
| 700 | 1 | _aTintori, Cristina | |
| 700 | 1 | _aManetti, Fabrizio | |
| 700 | 1 | _aClotet, Bonaventura | |
| 700 | 1 | _aBotta, Maurizio | |
| 700 | 1 | _aEsté, José A | |
| 773 | 0 |
_tVirology _gvol. 343 _gno. 1 _gp. 141-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.virol.2005.08.007 _zAvailable from publisher's website |
| 999 |
_c15800828 _d15800828 |
||